Thursday 31 March 2016

Vertebral Technologies, Inc. - Product Pipeline Analysis, Trend And Growth Report, 2015 : MarketResearchReports.Biz



MarketResearchReports.Biz announces addition of new report“ Vertebral Technologies, Inc. - Product Pipeline Analysis, 2015 Update ” to its database.

Vertebral Technologies, Inc. (VTI) is a medical device company that develops implantable spinal devices based on a proprietary intra-operative assembly technology. The company operates through its product segments, such as interfuse S device and intercushion disc nucleus replacement system. VTIs interfuse S implant is a modular implant which joins together via a rail-and-slot technique. The companys interfuse T device is inserted through the transforaminal approach. It markets its products through brand names InterFuse S, InterCushion and InterFuse T. VTI is headquartered in Minnetonka, Minnesota, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Download Sample copy of this Report @

Scope

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Vertebral Technologies, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Table of Content :

List of Tables 3
List of Figures 4
Vertebral Technologies, Inc. Company Snapshot 5
Vertebral Technologies, Inc. Company Overview 5
Key Information 6
Vertebral Technologies, Inc. Pipeline Products and Clinical Trials Overview 7
Vertebral Technologies, Inc. - Major Products and Services 9
Vertebral Technologies, Inc. Pipeline Products by Development Stage 10
Vertebral Technologies, Inc. Clinical Trials by Trial Status 12
Vertebral Technologies, Inc. Pipeline Products Overview 14
InterCushion Disc Nucleus Replacement System 14
InterCushion Disc Nucleus Replacement System Product Overview 14
InterCushion Disc Nucleus Replacement System Clinical Trial 15
InterFuse DA Intervertebral Body Fusion Device 16
InterFuse DA Intervertebral Body Fusion Device Product Overview 16

Browse Press Releases by Prweb :

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact us:

Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948

Maxillent Ltd. - Product Pipeline Market Analysis, Trends, Regulations And Competitive Landscape 2015



MarketReserchReports.biz has recently announced the addition of a market study “ Maxillent Ltd. - Product Pipeline Analysis, 2015 Update

Maxillent Ltd. (Maxillent) is a medical equipment company that develops solutions for dental implants. The companys products such as iRaise, iSure, prosthetics, surgical instruments and bone graft materials. It offers prosthetics such as healing abutments, impression transfers and analogs, cement retained restoration, screw retained restoration and over-denture restoration. Maxillents iRaise Sinus Lift System transforms a traumatic surgical intervention into a simple, minimally invasive and trauma-free procedure. The company provides solutions that advance implant dentistry. It distributes its products through a network of distributors in Belgium, Luxembourg, France, Hong Kong, Romania and the UK. Maxillent is headquartered in Herzliya, Israel.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Maxillent Ltd.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Download Sample copy of this Report at:

Reasons to buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Browse Our Press Releases by Prnewswire: http://www.prnewswire.com/news/marketresearchreports.biz

Table Of Content

List of Tables 3
List of Figures 4
Maxillent Ltd. Company Snapshot 5
Maxillent Ltd. Company Overview 5
Key Information 6
Maxillent Ltd. Pipeline Products and Clinical Trials Overview 7
Maxillent Ltd. Pipeline Products by Development Stage 10
Maxillent Ltd. Pipeline Products Overview 12
Healing Abutments 12
Healing Abutments Product Overview 12
iRaise - Sinus Lift Implant 13
iRaise - Sinus Lift Implant Product Overview 13
iSure Dental Implant 14
iSure Dental Implant Product Overview 14
Maxillent Surgical Instruments 15
Maxillent Surgical Instruments Product Overview 15

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

New Study On BioFire Diagnostics, Inc. - Product Pipeline Analysis And Forecast Report, 2015



MarketResearchReports.Biz announces addition of new report" BioFire Diagnostics, Inc. - Product Pipeline Analysis, 2015 Update "to its database.

BioFire Diagnostics, Inc. (BioFire Diagnostics) a subsidiary of bioMerieux S.A. is a medical device company that offers molecular diagnostic products. The company offers products such as The FilmArray. Its FilmArray product is a multiplex PCR system, which is used in the complex diagnostic situations. BioFire Diagnostics product find application in the upper respiratory tract infections, identification of organisms in positive blood cultures, gastrointestinal infections, meningitis, and lower respiratory tract infections. The companys product detects viruses, bacteria, yeast, parasites and antimicrobial resistance genes. It was formerly known as Idaho Technology, Inc. BioFire Diagnostics is headquartered in Salt Lake, Utah, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company BioFire Diagnostics, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Download Sample copy of this Report at

Reasons to buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

List of Tables 4
List of Figures 5
BioFire Diagnostics, Inc. Company Snapshot 6
BioFire Diagnostics, Inc. Company Overview 6
Key Information 7
BioFire Diagnostics, Inc. Pipeline Products and Clinical Trials Overview 8
BioFire Diagnostics, Inc. Pipeline Products by Development Stage 11
BioFire Diagnostics, Inc. Clinical Trials by Trial Status 13
BioFire Diagnostics, Inc. Pipeline Products Overview 15
FilmArray Biothreat-E Test 15
FilmArray Biothreat-E Test Product Overview 15
FilmArray Direct Sepsis Panel 16
FilmArray Direct Sepsis Panel Product Overview 16

Browse More PressRelease:

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948

Research And Market Forecast On Obsessive-Compulsive Disorder - Pipeline Review, H1 2016



" Obsessive-Compulsive Disorder - Pipeline Review, H1 2016 "is the latest addition to MarketResearchReports.Biz industry research reports collection.

Global Markets Directs, Obsessive-Compulsive Disorder - Pipeline Review, H1 2016, provides an overview of the Obsessive-Compulsive Disorder pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Obsessive-Compulsive Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Obsessive-Compulsive Disorder and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Download Sample copy of this Report at : http://www.marketresearchreports.biz/sample/sample/676888

Scope

  • The report provides a snapshot of the global therapeutic landscape of Obsessive-Compulsive Disorder
  • The report reviews pipeline therapeutics for Obsessive-Compulsive Disorder by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved Obsessive-Compulsive Disorder therapeutics and enlists all their major and minor projects
  • The report assesses Obsessive-Compulsive Disorder therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news related to pipeline therapeutics for Obsessive-Compulsive Disorder

Reasons to buy

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Obsessive-Compulsive Disorder
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Obsessive-Compulsive Disorder pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Browse Press Releases by Prweb :

Table of Contents

List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Obsessive-Compulsive Disorder Overview 6
Therapeutics Development 7
Pipeline Products for Obsessive-Compulsive Disorder - Overview 7
Pipeline Products for Obsessive-Compulsive Disorder - Comparative Analysis 8
Obsessive-Compulsive Disorder - Therapeutics under Development by Companies 9
Obsessive-Compulsive Disorder - Therapeutics under Investigation by Universities/Institutes 10
Obsessive-Compulsive Disorder - Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Obsessive-Compulsive Disorder - Products under Development by Companies 14

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

Wednesday 30 March 2016

Mitral Regurgitation Clinical Trials Review, H1 : Global Market Key Industry, Trend, Growth And Forecast Report 2016



"The Report Mitral Regurgitation Global Clinical Trials Review, H1, 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

GlobalData's clinical trial report, Mitral Regurgitation Global Clinical Trials Review, H1, 2016" provides an overview of Mitral Regurgitation clinical trials scenario. This report provides top line data relating to the clinical trials on Mitral Regurgitation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Download Sample copy of this Report at: http://www.marketresearchreports.biz/sample/sample/676723



Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Browse Our Press Releases by Prnewswire:

Table Of Content

Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Clinical Trials by G7 Countries: Proportion of Mitral Regurgitation to Cardiovascular Clinical Trials 11
Clinical Trials by Phase in G7 Countries 12
Clinical Trials in G7 Countries by Trial Status 13

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

Reperfusion Injury Global Clinical Trials Review, H1, 2016



MarketResearchReports.Biz announces addition of new report" Reperfusion Injury Global Clinical Trials Review, H1, 2016 "to its database.

Market Research's clinical trial report, Reperfusion Injury Global Clinical Trials Review, H1, 2016" provides an overview of Reperfusion Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Reperfusion Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Download Sample copy of this Report at

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Reperfusion Injury to Cardiovascular Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Reperfusion Injury to Cardiovascular Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18

Browse More PressRelease:

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074